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Abstract
Flap endonuclease 1 (FEN1) is a multifunctional DNA branching nuclease. 
Post-translational modifications (PTMs) exist in this protein widely, including 
phosphorylation, methylation, acetylation, ubiquitination and small ubiquiti-
nation modification (SUMO). Here, we make a summary for those PTMs studies 
on FEN1, to illustrate relationships between mutations of those amino acids 
and their functions alteration of FEN1. Numerous evidences have confirmed 
that dysfunction of FEN1 would lead to genome instability, and then induce a 
variety of chromosome-related diseases ultimately, including tumors. On one 
hand, interaction partner also stimulates FEN1 nuclease activity, to further 
ensure an effective role in the processing of different DNA structures; on the 
other hand, PTMs may regulate protein-protein interactions and FEN1’s cellular 
localization.
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1. Introduction
Flap endonuclease 1 (FEN1) is one of the member of the 5′ nuclease superfamily 
with specific structure [1]. It could participate in Okazaki fragment maturation, 
removal of RNA primers in delayed strand replication, maintenance of telomeres, 
long base excision repair etc [2–8]. Therefore, we believe that the nuclease activity 
of FEN1 is to maintain genome stability, and it is a necessary condition for normal 
cell cycle progression. However, if FEN1 is activated on inappropriate time, it would 
result in interrupting the cell cycle and then cause DNA damage. Therefore, func-
tion of FEN1 must be performed at a precise location within a suitable protein com-
plex in appropriate time. Dysregulation of FEN1 activity may lead to destruction of 
genetic information encoded in DNA and disrupt cell cycle. Studies have found that 
the expression of endogenous FEN1 increases in the G1 phase, reaches a peak in the 
S phase, and then drops sharply in the subsequent G2/M phase [9]. A large number 
of experiments have shown that FEN1 could undergo methylation [10], phosphory-
lation [11], SUMOylation [12, 13] and ubiquitination, a series of post-translational 
modifications (PTMs), finally FEN1 may degrade through the proteasome pathway 
in the G2/M phase [14].
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2. PTMs of FEN1
2.1 Methylation and phosphorylation of FEN1
In order to complete lagging strand DNA synthesis, mammals need to efficiently 
and accurately process up to 50 million Okazaki fragments in each cell cycle, and 
researchers have found that FEN1 plays an important role [15, 16]. Henneke et al. 
found that methylation and phosphorylation are important signals for the binding 
and dissociation of FEN1 and proliferating cell nuclear antigen (PCNA) replicas 
[11, 17]. Methylation promotes FEN1 binding to PCNA. Interacting with PCNA, 
Pol-δ, replication protein A and DNA ligase I, FEN1 removes RNA primers during 
DNA replication [18], and then be phosphorylated, resulting in disassociation from 
DNA complex and entering the next step [19].
2.2 SUMO3 modification of phosphorylated FEN1
After completing the DNA synthesis of the lagging strand, phosphorylated 
FEN1 is dissociated from the DNA complex [19]. Hietakangas et al. and Mohideen 
et al. [20, 21] speculated that it was modified by SUMO3, and they used SUMO3 
to measure the SUMOylation for phosphorylated FEN1 in vitro, and compared it 
with the unphosphorylated FEN1. Results showed that SUMOylation efficiency 
of phosphorylated FEN1 was significantly higher than that of unphosphorylated. 
Guo et al. co-transfected HeLa cells with a plasmid encoding His-SUMO3 and 
WT FEN1, S187A mutant (phosphorylated deficient) or S187D mutant (sustained 
phosphorylated) for FEN1’s phosphorylation study [19]. Compared with WT 
FEN1, S187A prevented FEN1 from undergoing SUMOylation, while S187D was the 
opposite. Henneke et al. treated the cells with Olomoucine, SUMO3 modification of 
WT FEN1 and S187D FEN1 was inhibited significantly [20]. Those indicated that 
SUMO3 modification of FEN1 is regulated by the phosphorylation of FEN1 at S187 
(Figure 1A).
2.3 Degradation of FEN1 mediated by SUMO3
Small ubiquitin-related modifier (SUMO) molecule is a newly discovered 
ubiquitin-like molecule, which participates in protein PTMs and plays an important 
role [22]. Mammals have SUMO1, SUMO2 and SUMO3, these 3 paralogs passed 
through 2 different enzymes, SUMO activating enzyme E1 and E2 [23, 24]. To 
test whether FEN1 degradation is related to SUMOylation or not, SUMO1, 2 and 3 
overexpressing level for FEN1 was determined. It has been found that overexpres-
sion of SUMO3 led to a sharply decrease in FEN1, which indicated that SUMO3 
modification is related to FEN1 degradation. SUMO3 modification site on FEN1 
was identified as lysine 168 (K168). To confirm this, mutated K168R and WT FEN1 
were subjected to SUMOylation in vitro. WT was SUMOylated, while K168R was 
not (Figure 1A). Then it was found that c-Myc-WT FEN1 was SUMOylated in cells, 
while SUMOylation of K168R was not. These showed that K168 is the main SUMO3 
modification site of FEN1. Further research found that K168R resists its degrada-
tion of FEN1 in G2/M phase, further confirming that degradation of FEN1 requires 
SUMO3 modification at K168.
2.4 UBE1/UBE2M/PRP19 complex ubiquitinated FEN1
Ubiquitination is a universal signal pathway for ubiquitin-proteasome degra-
dation for proteins [25]. After its ubiquitinated, FEN1 could be recognized as a 
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degradation target. Researchers determined that FEN1 is ubiquitinated in vitro and 
in vivo. Mass spectrometry showed that mutation of K354R abolished the ubiq-
uitination of FEN1 (Figure 1A), which confirmed K354 is the ubiquitination site 
indeed. Ubiquitination is similar to SUMOylation, both processes involve sequen-
tial reaction steps mediated by a set of enzymes [25, 26]. Only E1 (SAE1/SAE2) 
and E2 (Ubc9) have been found for SUMOylation. However, it was reported that 
there are dozens of proteins involved in ubiquitination [27], and 138 interacting 
proteins then have been identified, including UBE1 [28], UBE2M [29], PRP19 
[30] and UBQLN4 [31], which have been previously determined to play a role in 
ubiquitination pathway. It was reported that UBE1 has E1 ubiquitin-activation 
activity, UBE2M has E2 ubiquitin-binding activity, PRP19 has E3 ligase-activity, 
and UBLNQ4 may play a role in de-ubiquitination. It has also been found that the 
consumption of UBQLN4 had no effect on its ubiquitination, while consump-
tion of UBE1 and UBE2M eliminated its ubiquitination, while consumption of 
PRP19 showed that FEN1’s ubiquitination was significantly reduced. Purified 
UBE1, UBE2 and PRP19 were also tested, indicating that they could lead to FEN1’s 
ubiquitination in vitro.
2.5 FEN1 is degraded through the ubiquitin-proteasome pathway during G2/M
It has been showed that endogenous FEN1’s expression increased during G1 
phase, reached a peak in S phase, and then dropped sharply in G2/M phase, which 
indicated that FEN1 was differentially regulated during cell cycle progression. 
MG132 (Carbobenzoxyl-leucinyl-leucinyl- leucinal), the proteasome inhibitor, 
was used for study. Results showed that the level of FEN1 in G2/M phase increased, 
while the level in S phase did not change significantly, suggesting that degradation 
is regulated by the proteasome pathway (Figure 1B) [32].
2.6 Acetylation of FEN1
Hasan et al. found that the transcriptional co-activator P300 histone acetyltrans-
ferase could acetylate Lys354, Lys375, Lys377 and Lys380 residues of FEN1 [33]. 
Figure 1. 
(a) PTMs programmed mutation sites. Up is discovered modification sites. Down is predicted modification 
sites. A stands for acetylation; P stands for phosphorylation; M stands for methylation; U stands for 
ubiquitination; S stands for SUMOylation. (b) Model of sequential modifications to degrade FEN1. FEN1 is 
phosphorylated in late S phase, then dissociation from PCNA and the DNA replication fork. Once released 
from the DNA replication fork, phosphorylated FEN1 is then SUMOylated, which triggers ubiquitination by 
PRP19 and its degradation ultimately.
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Acetylation of FEN1 reduced the DNA binding ability and nuclease activity signifi-
cantly, and then inhibited the interaction between FEN1 and 9-1-1 complex (Rad9/
Rad1/Hus1 cell cycle checkpoint complex) [34], however, binding ability to PCNA 
was not affected [35]. Lys80, Lys267, Lys375, have been found as 3 acetylating sites 
[36]. Strangely, Lys80 and Lys267 were not found in previous studies, and functions 
of these new sites were still unclear. New acetylation sites, such as Lysl25, Lys252, 
Lys254 and Lys314, have also been identified then [37]. It showed that acetylation 
levels of K125A and K252/K254A mutants decreased significantly, indicating that 
these sites were key sites for FEN1’s acetylation. In addition, the proportion of G1 
phase for K125A and K252/K254A increased significantly. K252/K254A mutant cells 
were more sensitive to UV induced DNA damage [37]. These indicated that acety-
lating modification of those sites plays a role in maintaining the normal physiologi-
cal state of cells and their genomic stability.
2.7 Succinylation of FEN1
It has been found some succinylation modifications sites in FEN1 [38]. Lys200, 
Lys354 overlapped with some of identified acetylation sites, indicating that both 
were succinylation and acetylation modification sites for FEN1. As succinylation 
of lysine is more complex than acetylation, this modification may induce greater 
changes in chemical properties, structure and function of FEN1 [39]. Acetylation 
and succinylation of lysine are very important in gene transcription, cell metabo-
lism, and DNA damage response. In addition, overlap of these modification sites 
for acetylation and succinylation indicated that there may be some complementary, 
synergistic or antagonistic effect between those modifications.
3. Summary
PTMs occur sequentially in the degradation process of FEN1, and each PTM is 
necessary for the next reaction. The absence or inhibition of any step would prevent 
FEN1 from degrading successfully. Researchers have also found that overexpression 
of WT FEN1 caused 25% cells closed to tetraploidy, while 65% in K354A; just only 
5% in parental HeLa cells. It could be concluded that overexpression of FEN1 makes 
the chromosomal number in disorder. High FEN1 levels were usually observed in 
cancer cells. In addition, FEN1’s overexpression has been observed in a variety of 
cancers, which is a sign for poor prognosis.
Sequential PTMs of FEN1 in the cell cycle process, is the separation of 
methylated FEN1 from PCNA, first undergoes phosphorylation, though 
demethylation reaction after methylated FEN1 has still not been illustrated. 
Phosphorylation induces FEN1 to undergo SUMO3 modification, and SUMO3 
modification further stimulates ubiquitination. Finally, FEN1 is degraded 
through the proteasome pathway. Any residues of these PTMs have been 
mutated, degradation of FEN1 would be hindered. Therefore, there must be a 
precise regulation mechanism to ensure that FEN1 could function at suitable 
time. Numerous evidences have confirmed that the dysfunction of FEN1 would 
lead to instability of the genome, and induce a variety of chromosome-related 
diseases ultimately, including tumors. Interaction partners stimulate nuclease 
activity to further ensure an effective role of FEN1 in the processing of DNA 
structures, and PTMs also may regulate protein-protein interactions and FEN1’s 
localization in cells. In the future, it is believed that more mechanisms of FEN1 
PTMs’ function would be discovered, to understand cancers development better, 
and it also would benefit mankind clinically.
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